Skip to content

Comment on US FDA approves nasal spray alternative to EpiPen for allergic reactionsparent

Comments

Why are you linking 2016 articles in 2024? Back then the generic wasn't widely available

Because options prevent further monopoly activity that was proven to have happened (citations provided). You seem to have some interest in avoiding the truth and facts around this topic, which is odd. First “there was no monopoly,” and then “well, it was a while ago so it doesn’t matter now.” It happened, and it could happen again. Also, it isn’t enough to be generic based on manufacturing complexity and capacity, which can create a monopoly situation for a generic.

First “there was no monopoly,”

Nope, first "there is no monopoly". I don't give a shit about 2016

AboutSource Built by g1lg1l

Hackerly is an independent reader for Hacker News, built on the public HN API. Not affiliated with Y Combinator.